Protagonist Therapeutics, Inc Fair Value Adjustment of Warrants
Protagonist Therapeutics, Inc (PTGX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2019-03-12
- Protagonist Therapeutics, Inc fair value adjustment of warrants for the quarter ending 2017-12-31 was $0.00.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for the quarter ending 2017-09-30 was $0.00.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for the quarter ending 2017-06-30 was $0.00.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for fiscal 2018 was $0.00.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for fiscal 2016 was $525.00K.
- Protagonist Therapeutics, Inc fair value adjustment of warrants for fiscal 2015 was -$543.00K, a 162.27% decline from fiscal 2014.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $0.00 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $0.00 derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $0.00 derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | $525.00K 10-K · filed 2019-03-12 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-08-08 | $525.00K 10-Q · filed 2017-11-07 | $641.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | $525.00K 10-Q · filed 2017-08-08 | $641.00K derived: sum of 3 quarters · filed 2018-03-07 | -$164.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $525.00K 10-Q · filed 2017-05-10 | $641.00K derived: sum of 2 quarters · filed 2018-03-07 | -$164.00K derived: sum of 3 quarters · filed 2018-03-07 | -$28.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$689.00K derived: sum of 2 quarters · filed 2018-03-07 | -$553.00K derived: sum of 3 quarters · filed 2018-03-07 | -$543.00K 10-K · filed 2018-03-07 |
| 2015-09-30 | -$805.00K 10-Q · filed 2016-11-14 | -$669.00K derived: sum of 2 quarters · filed 2016-11-14 | -$659.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $136.00K 10-Q · filed 2016-09-15 | $145.00K 10-Q · filed 2016-09-15 | ||
| 2014-12-31 | $872.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |